At the forefront of pharmaceutical innovation, Virupaksha stands as a beacon of excellence in manufacturing high-purity Fluconazole, crucial for treating severe infections like cryptococcal meningitis. With an unwavering commitment to quality and safety, the company operates under stringent WHO-GMP guidelines, ensuring that every batch produced meets international standards for efficacy and purity.
Their state-of-the-art facilities are not only ISO 9001 certified—confirming their dedication to consistent quality management—but also ISO 14001 certified, highlighting their proactive approach to environmental sustainability in production processes. This meticulous attention to detail underscores Virupaksha’s mission: delivering pharmaceuticals that healthcare professionals can trust while contributing positively to the global community’s health outcomes.
Other Latest News
- Pharma Logistics: A Global Perspective January 23, 2026 8:25 pm CHEManager News Our insights have been published in various editions of CHEManager International. We covered North- and Latin America, Asia, Africa, and Russia, highlighting real-life project and operational experience, market specifics as well as trends we observed. …
- Comparator Drug Sourcing Market to Reach USD 2.72 Billion by 2033, Driven by Rising Global Clinical Trials and Outsourcing Trends – SNS Insider January 23, 2026 7:58 pm Business Upturn Global Comparator Drug Sourcing Market to Grow at 8.47% CAGR as Demand for Effective, Compliant, and On-Time Clinical Trial Supply Solutions Increases. Austin, Texas, Jan. 23, 2026 (GLOBE NEWSWIRE) — As per SNS Insider, the Comparator Drug Sourcing Market …
- 2025 Recap: Resilience and Reinvention in Indian Chemicals January 23, 2026 7:03 pm Chemical Industry Digest 2025 was a defining year for India’s chemical industry, marked by resilience, consolidation and strategic transformation. Despite global demand volatility and geopolitical uncertainties, Indian chemical companies strengthened their global footprint through …
- Lipid Nanoparticle Manufacturing Market: An 18.9% CAGR Market Driven by Nucleic Acid Therapies January 23, 2026 3:00 pm EIN Presswire Ottawa, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The global lipid nanoparticle manufacturing market size is calculated at USD 565 million in 2026 and is expected to reach around USD 2243 million by 2034, growing at a CAGR of 18.9% for the forecasted period. The …
- Rx Rundown: Bristol Myers Squibb, Corxel Pharmaceuticals, GSK and more January 23, 2026 2:20 pm Medical Marketing and Media Check out this week’s medical marketing news, dealmaking and industry chatter. Deals: GSK is set to buy Rapt Therapeutics in a $2.2 billion deal. AstraZeneca agreed to a $630 million pact to secure remaining rights to armored CAR-T from AbelZeta. Bristol …
- Bio-based Pouching Material Market Trends 2026-35 January 23, 2026 2:14 pm EIN Presswire Ottawa, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The bio-based pouching material market is forecasted to expand from USD 775.78 million in 2026 to USD 1256.06 million by 2035, growing at a CAGR of 5.5% from 2026 to 2035. The market is experiencing rapid growth, …
- Sun Pharma unit recalls antibacterial & anti-inflammatory drug in US January 23, 2026 1:39 pm ETPharma.com New Delhi: Sun Pharmaceuticals Industries Inc, is undertaking two separate voluntary recalls of antibacterial solution, ‘Clindamycin Phosphate’ and anti-inflammatory steroid ‘Fluocinolone Acetonide’ in the US According to the US FDA latest enforcement …
- TinyML: Emerging pillar of AI—enterprises must watch it closely January 23, 2026 10:18 am Coingeek Homepage > News > Tech > TinyML: Emerging pillar of AI—enterprises must watch it closely This post is a guest contribution by George Siosi Samuels, managing director at Faiā. See how Faiā is committed to staying at the forefront of technological …
- Pouch Materials for Pharmaceutical Market Trends 2025-35 January 23, 2026 6:18 am EIN Presswire Ottawa, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The global pouch materials for pharmaceutical market generated revenue of USD 11.25 billion in 2026 and this figure is projected to grow to USD 19.5 billion in 2035, according to research conducted by Towards …
- Ravindranath Kancherla on why most healthcare innovation never reaches patients and how India can change that January 23, 2026 5:28 am The Economic Times Dr. Ravindranath Kancherla has dedicated more than 40 years to improving healthcare, transitioning from a transplant surgeon to establishing a prominent network of tertiary-care hospitals, all while focusing on both outstanding patient care and effective …
- PMMI Pharma Infographic Reveals Manufacturing and Regulatory Challenges as Well as Future Packaging Trends January 23, 2026 1:14 am Manufacturing Tomorrow Research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome operational issues and support growth. Herndon, Va.; Jan. 22, 2026 — The pharmaceutical industry is in a period of sustained expansion, …
- Gastroesophageal Reflux Disease Market in the US to Show Promising Growth at a CAGR of 6% During the Forecast Period (2025-2034) | DelveInsight January 23, 2026 12:02 am WFMZ - Pennsylvania The gastroesophageal reflux disease market continues to be constrained by a limited number of approved treatment options and persistent unmet needs, particularly among patients who do not achieve adequate control with PPIs. Nevertheless, advancements in …
- PCR Packaging for Pharma and OTC Market Size, Share, Forecast: Growth Segment, Value Chain Insights. Opportunity Mapping January 22, 2026 9:56 pm EIN Presswire PCR Packaging for Pharma and OTC Market Size and Share Forecast Outlook 2026 to 2036 ROCKVILLE, MD, UNITED STATES, January 23, 2026 /EINPresswire.com/ -- The PCR Packaging for Pharma and OTC Market is poised for strong global growth as …
- 100% Bonus Is Back: QPP Turns Buildings Into Deductions January 22, 2026 8:19 pm Industry Today OBBBA’s new Section 168(n) lets manufacturers expense qualifying facility costs – if timing, use, and documentation line up. Cost seg helps. By Michael Webb and Ed Meyette Manufacturers – including life sciences and pharmaceutical manufacturers – know that …
- Moderna-Merck mRNA Vaccine Slashes Melanoma Recurrence by 49% at 5 Years January 22, 2026 7:07 pm WebProNews Enduring Promise: How Moderna and Merck’s mRNA Vaccine is Redefining Melanoma Survival In the realm of oncology, where breakthroughs often flicker briefly before fading, a collaboration between biotech giants Moderna and Merck has delivered a beacon of …
- Parenteral Drug Association to host innovation in sustainable packaging workshop at Pharmapack 2026 January 22, 2026 5:46 pm World Pharma Today - Advertisement - The Parenteral Drug Association (PDA) will host a half-day workshop titled “PDA Innovation in Sustainable Packaging Workshop 2026” on Day 1 of Pharmapack Europe in Paris. Taking place on the morning of 22nd Jan, the session will explore …
- BD and Ypsomed develop new version of Neopak XtraFlow syringe January 22, 2026 4:17 pm Medical Device Network Becton, Dickinson and Company (BD) and Ypsomed have announced an expansion of their partnership with the development of a 5.5ml version of the BD Neopak XtraFlow glass prefillable syringe. The new syringe is designed for full compatibility with Ypsomed’s …
- Recyclable mono-material PE Market Trends 2026-2035 January 22, 2026 3:31 pm EIN Presswire Ottawa, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The global recyclable mono-material PE market reported a value of USD 1.21 billion in 2025, and according to estimates, it will reach USD 3.14 billion by 2035, as outlined in a study from Towards Packaging, a …
- High-Barrier Tie-Layer Resins Market Set to Reach USD 3.5 Billion by 2036 on Advanced Packaging Demand January 22, 2026 3:23 pm EIN Presswire Global high-barrier tie-layer resins demand accelerates as multilayer food and pharma packaging drives 6.5% CAGR through 2036. NEWARK, DE, UNITED STATES, January 22, 2026 /EINPresswire.com/ -- Market Overview: Structural Growth Anchored in …
- Biopharmaceutical 3PL Market Set to Grow USD 276.24 Bn as Advanced Therapies and Vaccines Drive Global Demand January 22, 2026 3:00 pm EIN Presswire Ottawa, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The global biopharmaceutical third-party logistics market size is calculated at USD 163.04 billion in 2026 and is expected to reach around USD 276.24 billion by 2034, growing at a CAGR of 6.62% for the forecasted …
- Rewiring Pharma R&D Workflows with Advanced Digital Technologies January 22, 2026 1:39 pm ETPharma.com Hyderabad: Transforming compelling science into commercially viable breakthroughs has long been the cornerstone of pharmaceutical growth. Sustained investment in research remains central to business strategy, enabling differentiated portfolios, mitigating …
- API makers seek import curbs, subsidies for GMP upgrade January 22, 2026 1:14 pm ETPharma.com New Delhi: Reeling from aggressive pricing by Chinese competitors and mounting compliance costs linked to the revised Schedule M norms, India’s bulk drug manufacturers are pressing for stronger import curbs and targeted subsidies, including soft financing, …
- Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix® Long-Term Economic and Development Profile January 22, 2026 12:30 pm EIN Presswire Amendment reduces and simplifies royalty structure on Teverelix® from ~4% to 2% while preserving global rights and IP control The Company is developing Teverelix® as a first in class market product for Acute Urinary Retention Relapse prevention (AURr) and …
- Clinical Nail Care Products Market to Surpass USD 4.5 Billion by 2036 as Medical Management Replace Cosmetic Concealment January 22, 2026 10:11 am EIN Presswire USA clinical nail care sales are growing at 5.2% CAGR through 2036, driven by podiatric awareness, strong retail presence, laser therapies, and local players. NEWARK, DE, UNITED STATES, January 22, 2026 /EINPresswire.com/ -- The global clinical …
- India likely to grow 6.5-7% in FY27 amid global risks January 22, 2026 9:05 am ETRetail.com New Delhi: India is likely to clock real gross domestic product (GDP) growth of 6.5-7% in the coming fiscal, supported by the continuing growth momentum, though policymakers should remain mindful of the looming geopolitical risks and weak global demand, …